Flow adjustable artery shunt

• US 5,662,711 A
• Filed: 06/07/1995
• Issued: 09/02/1997
• Est. Priority Date: 06/07/1995
• Status: Expired due to Term

• Current Assignee: William Douglas
• Original Assignee: William Douglas
• Inventors: Douglas, William
• Primary Examiner(s): Milano, Michael J.
• Application Number:
  US08/477,184
• Time in Patent Office: 818 Days
• Field of Search: 604/8, 604/9, 623/3, 623/12, 623/1
• US Class Current: 604/9
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: A61F 2/06 Blood vessels
• CPC Class Codes: A61F 2/24 Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body

Abstract

An apparatus and method for treating congenital heart defects, such as cyanotic heart defects which includes a shunt implanted within a patient'"'"'s cavity for communicating blood from the patient'"'"'s arterial system to the patient'"'"'s pulmonary system. An adjustable flow restrictor forms part of the shunt and is operative to adjust the effect of cross-section of the shunt thereby varying the blood flow rate in the shunt. An oximeter monitors the oxygen saturation levels in the blood and in cooperation with a restrictor control varies inflation of the bladder to maintain an oxygen saturation level in the blood between predetermined limits.

Claims

1. A method for treating a congenital heart defect, comprising the steps of:

a) implanting a shunt within a patient'"'"'s chest cavity for communicating arterial blood to a pulmonary artery;

b) providing an adjustable flow restriction within said shunt for adjusting the blood flow rate in said shunt;

c) adjusting said flow restriction to maintain the oxygen level in said blood within desired limits.

2. The method of claim 1 further comprising the step of monitoring the oxygen level of the blood flowing through said shunt using a sensor.

3. The method of claim 1 further comprising the step of providing an expandable bladder as part of said shunt and providing a fluid supply for filling said bladder in order to expand said bladder in the flow path defined by said shunt whereby a restriction to blood flow is provided depending on the extent to which said bladder is expanded.

4. The method of claim 2, wherein said step of monitoring the oxygen level of the blood flowing through said shunt is provided by an oximeter having a sensing probe attached to said shunt.

5. The method of claim 3, further comprising the step of periodically expanding said bladder to a predetermined state in order to inhibit the formation of pseudo-intima.

6. An apparatus for treating congenital heart defects, comprising:

a) a systemic-pulmonary shunt implanted within a patient'"'"'s chest cavity having one end adapted to be attached to the patient'"'"'s arterial system and another end adapted to be attached to the patient'"'"'s pulmonary system and operative to communicate blood from the patient'"'"'s arterial system to the patient'"'"'s pulmonary system;

b) an adjustable flow restrictor forming part of said shunt, said adjustable flow restrictor having at least three effective sizes;

c) an oximeter including a probe in communication with blood flowing in said shunt;

d) a restrictor control system responsive to said oximeter to vary the effective size of said flow restrictor, said effective size of said flow restrictor being a function of the oxygen saturation level in the blood whereby a blood flow rate through said shunt is adjusted to maintain a oxygen saturation level in said blood between predetermined limits, one limit being substantially 40% and the other limit being substantially 99%; and

,

e) an implantable power source for providing power for said control system.

7. The apparatus of claim 6, wherein said adjustable flow restrictor comprises an inflatable bladder.

8. The apparatus of claim 7, wherein said bladder is constructed of a blood compatible material having a compliance that is greater than that of a material from which the shunt is constructed.

9. The apparatus of claim 6, wherein said adjustable flow restrictor comprises a bladder formed by a sheet of elastomeric material, a periphery of said bladder material being fastened to an inside portion of said shunt.

10. The apparatus of claim 7, wherein said restrictor control includes a pump and a reservoir of fluid, the fluid in said reservoir being communicated to and from said bladder by said pump in order to inflate said bladder thereby reducing an effective cross-section of said shunt.

11. The apparatus of claim 10, wherein said pump is controlled by said restrictor control system and is operative to fill and deflate said bladder in response to sensed oxygen saturation levels in the blood stream.

12. The apparatus of claim 11, further comprising a means for expanding said bladder periodically in order to inhibit or dislodge the formation of pseudo-intima.

13. The apparatus of claim 11, wherein said controller stores target values for said oxygen saturation levels and which are compared with said sensed oxygen saturation levels in order to determine whether an inflation state of said bladder needs to be adjusted.

14. The apparatus of claim 13, further comprising external devices for sending signals to said restrictor control system in order to change said stored target saturation levels.

15. An apparatus for treating congenital heart defects, comprising:

a) a systemic-pulmonary shunt implanted within a patient'"'"'s chest cavity having one end adapted to be attached to the patient'"'"'s arterial system and another end adapted to be attached to the patient'"'"'s pulmonary system and operative to communicate blood from the patient'"'"'s arterial system to the patient'"'"'s pulmonary system;

b) an adjustable flow restrictor forming part of said shunt, said adjustable flow restrictor having at least three effective sized;

c) an oxygen sensor in communication with blood flowing in said patient;

d) a restrictor control system responsive to said sensor to vary the effective size of said flow restrictor whereby a blood flow rate in said shunt is adjusted to maintain an oxygen saturation level in said blood between predetermined limits, one limit being substantially 40% and the other limit being substantially 99%; and

,

e) an implantable power source for providing power for said control system.

16. The apparatus of claim 15, wherein said oxygen sensor comprising an oximeter.

17. The apparatus of claim 15, wherein said adjustable flow restrictor comprises an inflatable bladder for adjusting the effective size of said restrictor.

18. An apparatus for treating congenital heart defects, comprising:

a) a systemic-pulmonary shunt implanted within a patient'"'"'s chest cavity having one end adapted to be attached to the patient'"'"'s arterial system and another end adapted to be attached to the patient'"'"'s pulmonary system and operative to communicate blood from the patient'"'"'s arterial system to the patient'"'"'s pulmonary system;

b) an adjustable flow restrictor forming part of said shunt, said adjustable flow restrictor having at least three effective sizes;

c) a restrictor control system operative to vary the effective size of said flow restrictor whereby a blood flow rate in said shunt is adjusted to maintain a oxygen saturation level in said blood between predetermined limits, one limit being substantially 40% and the other limit being substantially 99%; and

,

d) an implantable power source for providing power to said control system.

19. The apparatus of claim 18, further comprising an oxygen sensor for monitoring the oxygen saturation level in the patient'"'"'s blood.

20. The apparatus of claim 19, wherein said restrictor control system is responsive to oxygen saturation levels sensed by said sensor.

21. The apparatus of claim 19, wherein said oxygen sensor comprises an oximeter.

22. The apparatus of claim 21, wherein said oximeter directly monitors the oxygen saturation level of blood flowing in said shunt.

23. The apparatus of claim 18, further comprising a means for receiving control signals from a device external to the patient'"'"'s chest, said restrictor control system responding to said control signals to change the effective size of said flow restrictor.

24. The apparatus of claim 18, wherein said predetermined limits of the oxygen saturation level are stored within said restrictor control system.

25. The apparatus of claim 24, wherein said predetermined limits are changeable by control signals issued by a device external to said patient'"'"'s chest.

26. An apparatus for treating congenital heart defects, comprising:

a) a shunt implanted within a patient'"'"'s chest cavity for communicating blood from the patient'"'"'s arterial system to the patient'"'"'s pulmonary system;

b) an adjustable flow restrictor forming part of said shunt;

c) a restrictor control system operative to vary an effective size of said flow restrictor whereby a blood flow rate in said shunt is adjusted to maintain a oxygen saturation level in said blood between predetermined limits;

d) an oxygen sensor for monitoring the oxygen saturation level in the patient'"'"'s blood, said oxygen sensor comprising an oximeter that directly monitors the oxygen saturation level of blood flowing in said shunt; and

,

e) an implantable power source for providing power to said control system.

27. For a patient having a first vascular structure and a second vascular which under normal conditions receives blood that has travelled through the first vascular structure, an apparatus for treating congenital heart defects, comprising:

a) a shunt implanted within a patient'"'"'s chest cavity having one end adapted to be attached to the first vascular structure of the patient and another end adapted to be attached to the second vascular structure of the patient and operative to communicate blood from the patient'"'"'s second vascular structure to the patient'"'"'s first vascular structure;

b) an adjustable flow restrictor forming part of said shunt, said adjustable flow restrictor having at least three effective sizes;

c) an oximeter including a sensor for monitoring the oxygen level of blood flowing through the patient;

d) a restrictor control system responsive to said oximeter to vary the effective size of said flow restrictor said effective size of said flow restrictor being a function of the oxygen saturation level in the blood whereby a blood flow rate through said shunt is adjusted to maintain a oxygen saturation level in said blood between predetermined limits, one limit being substantially 40% and the other limit being substantially 99%; and

,

e) an implantable power source for providing power for said control system.